UNITED STATES of America, Plaintiff-Appellant, John L. Doyle, III, M.D.; Mariann Doyle, Plaintiffs-Appellees, v. HEALTH POSSIBILITIES, P.S.C.; Urgent Treatment Centers of Kentucky, Inc.; Barry Burchett, M.D.; John Langefeld, M.D.; John Does, sued as unknown persons; Physicians of UTC, P.S.C., Defendants-Appellees.
No. 99-5259.
United States Court of Appeals, Sixth Circuit.
Decided March 22, 2000
Argued Jan. 27, 2000
Thomas Lee Gentry, Asst. U.S. Atty., Lexington, KY, Thomas W. Miller (argued and briefed), Miller, Griffin & Marks, Lexington, KY, for Plaintiffs-Appellees John L. Doyle, III, M.D., and Mariann Doyle.
Stephen L. Barker (briefed), Douglas L. McSwain (briefed), Sturgill, Turner, Barker & Maloney, Lexington, KY, for Defendant-Appellee Health Possibilities, P.S.C.
Richard F. O‘Malley, Jr. (argued and briefed), Peter J. Tarsney, Constantine L. Trala, Jr., Sidney & Austin, Chicago, IL, Margaret Pisacano, Stites & Harbison, Lexington, KY, for Defendants-Appellees Urgent Treatment Centers of Kentucky, Inc., Barry Burchett, M.D. and John Langefeld, M.D.
Douglas L. McSwain, Sturgill, Turner, Barker & Maloney, for Defendant-Appellee John Does.
Hiram Ely, III (briefed), Vickie Yates Brown, Greenebaum, Doll & McDonald, Louisville, KY, for Defendant-Appellee Physicians of UTC, P.S.C.
Before: JONES, NORRIS, and SILER, Circuit Judges.
OPINION
NATHANIEL R. JONES, Circuit Judge.
Raising an issue of first impression in this circuit, this case requires that we determine whether the Attorney General‘s consent is required before a private plaintiff may settle or otherwise dismiss an action under the qui tam provisions of the False Claims Act (“FCA“),
I.
Plaintiffs-Appellees Dr. John and Mariann Doyle were formerly employed by Defendant-Appellee Health Possibilities, P.S.C. Health Possibilities is a medical services provider that staffed various health clinics in Lexington, Kentucky, including a number of clinics owned and operated by Defendants-Appellees Urgent Treatment Centers of Kentucky, Inc. (“UTC“), Dr. Barry Burchett, and Dr. John Langefeld.
As required by
Shortly after filing the Second Amended Complaint, the Doyles and Defendants reached a settlement agreement. Under the agreement, the qui tam suit was settled in conjunction with Dr. Doyle‘s pending state court defamation action. Regarding the qui tam suit, the Doyles agreed to release Defendants from all claims “of any kind or nature whatsoever” that related to their submission of Medicare claims, or claims under any other federal health care reimbursement program. J.A. at 204-205. In exchange, Defendants agreed to pay the Doyles $150,000 in attorneys fees and costs, and to implement a corporate compliance program designed to ensure that they prospectively complied with federal and state law governing medical reimbursements. See J.A. at 263-268. While the Doyles did not receive any damages for releasing the FCA claims, Dr. Doyle did receive $150,000 in damages—and $50,000 for attorneys’ fees and costs—for settling the defamation action. See Gov‘t Br. at 8; UTC Br. at 9-10; J.A. at 230. While
Asserting that the settlement did not protect the interests of the public, the United States objected to the settlement. The government contended that
The district court rejected the government‘s argument that
The Doyles and Defendants subsequently twice modified the release language. The final language provided that all civil claims, whether judicial or administrative, would be released in exchange for the previously approved fees payments and the corporate compliance plan. J.A. at 310. The district court thereafter approved the settlement and dismissed the action, reiterating its earlier holding that after the government declines intervention, a relator may settle a
II.
This appeal turns entirely on the scope of the FCA‘s command that qui tam suits may not be dismissed without the Attorney General‘s consent. Section
A person may bring a civil action for a violation of
Section 3729 for the person and for the United States Government. The action shall be brought in the name of the Government. The action may be dismissed only if the court and the Attorney General give written consent to the dismissal and their reasons for consenting.
While the interpretation of the “consent” requirement‘s breadth presents an issue of first impression in this Court, two of our sister circuits have directly confronted this issue.4 In Killingsworth v. Northrop Corp., 25 F.3d 715, 722 (9th Cir. 1994), the Ninth Circuit held that the “consent” provision is not absolute, but applies only when the United States is contemplating its initial intervention decision. The Ninth Circuit held that when the Attorney General declines to intervene, the relator no longer needs her consent to settle, and the government is restricted to challenging the settlement for “good cause” under
On the other hand, the Fifth Circuit, concluding that the plain language of
We now join the Fifth Circuit in rejecting the Ninth Circuit‘s analysis, and hold that a relator may not seek voluntary dismissal of any qui tam action without the Attorney General‘s consent. Section
Moreover, we find that the clear import of this language is strengthened by the FCA‘s purpose, structure and legislative history. Congress’ manifest desire to ensure that the government retains significant authority to influence the outcome of qui tam actions—even when it decides not to intervene—is entirely consistent with the nature of qui tam litigation. The FCA‘s qui tam provision is
passed upon the theory, based on experience as old as modern civilization, that one of the least expensive and most effective means of preventing frauds on the Treasury is to make the perpetrators of them liable to actions by private persons acting, if you please, under the strong stimulus of personal ill will or the hope of gain.
Hughes Aircraft Co. v. United States ex rel. Schumer, 520 U.S. 939, 949 (1997) (internal quotations and citation omitted). Because the scope of fraud against the government is much broader than the government‘s ability to detect it, the qui tam provisions allow the government to uncover fraud that it would not otherwise be able to discern. See United States ex rel. Springfield Terminal Ry. Co. v. Quinn, 14 F.3d 645, 650-51 (D.C. Cir. 1994). Pursuant to this goal, the FCA provides private actors with a variety of incentives to bring qui tam actions, and significant influence over the ensuing development of qui tam suits—including “the right to conduct the action” when the government decides not to intervene. See
However, given that private opportunism and public good do not always overlap, see Searcy, 117 F.3d at 160; see also United States ex rel. Rabushka v. Crane Co., 40 F.3d 1509, 1519 (8th Cir. 1994) (Magill, J., dissenting) (noting that the qui tam provisions “set[] a rogue to catch a rogue“) (citation omitted), and that the harms redressed by the FCA belong to the government, see United States ex rel. Kreindler & Kreindler v. United Technologies Corp., 985 F.2d 1148, 1154 (2d Cir. 1993), the FCA provides a number of mechanisms to ensure that the government retains significant authority to regulate qui tam litigation. See Milam, 961 F.2d at 49 (noting that the government maintains “extensive power” to control the course of qui tam litigation). For example, not only does the government retain absolute authority to intervene and “proceed” with an action during the sixty days after the complaint was filed, it can intervene for “good cause” at any time in the litigation. See
In our view, the power to veto a privately negotiated settlement of public claims is a critical aspect of the government‘s ability to protect the public interest in qui tam litigation. The FCA is not designed to serve the parochial interests of relators, but to vindicate civic interests in avoiding fraud against public monies. See United States v. Northrop Corp., 59 F.3d 953, 968 (9th Cir. 1995) (“[T]he private right of recovery created by the qui tam provisions of the FCA exists not to com-
The recovery division requirements of the FCA provide further incentive for the over-broad release of government claims. See
[R]elators can manipulate settlements in ways that unfairly enrich them and reduce benefits to the government. This case presents a relator who allegedly wants to trade on the defendants’ desire to maximize preclusive effects. Plaintiffs ordinarily prefer to keep their options open; agreeing not to bring future suits can be costly. In qui tam litigation, however, there is a danger that a relator can boost the value of settlement by bargaining away claims on behalf of the United States [at little cost to himself].
Searcy, 117 F.3d at 160. The potential for such profiteering is exacerbated when, as here, a relator couples FCA claims with personal claims. In these circumstances, a relator can avoid the FCA‘s recovery division requirements by allocating settlement monies to the personal claims. Relators can thereby use the bait of broad claim preclusion to secure large settlements, while steering any monetary recovery to the personal action. See Searcy, 117 F.3d at 160 (noting that in Killingsworth litigation, relator settled an FCA claim for $1.5 million, but settled a personal wrongful termination claim for $2.7 million, illustrates manipulation of qui tam suit). See also Christopher C. Frieden, Comment, Protecting the Government‘s Interests: Qui Tam Actions Under the False Claims Act and the Government‘s Right to Veto Settlements of Those Actions, 47 Emory L.J. 1041, 1071 (1998) (noting the use of “sweetheart settlements” to avoid the seventy percent allocation). Indeed, in this case, the Doyles received no monetary recovery on the FCA claim, but Dr. Doyle did manage a $150,000 personal recovery on the defamation claim. While we make no particular conclusions of the propriety of the defamation settlement in this case, we merely note that the potential for abuse exists and veto authority is essential to ensuring the public interest is vindicated. Accordingly, we conclude that the policies served by the veto power are entirely consistent with the conclusion compelled by
This holding is also consistent with other portions of
In terms of statutory context and structure, we note that the consent language appears immediately after the provisos stipulating that a relator acts “for [himself] and for the United States Government,” and that “[t]he action shall be brought in the name of the Government.” See
Additionally, nothing in the statute‘s legislative history compels a result contrary to
Moreover, there is no specific indication that any of the amendments to the FCA were intended to limit the “consent” requirement to the sixty-day intervention period. It is true, as the Killingsworth court
However, simply because Congress intended to provide more incentives to private parties to bring qui tam actions does not signal that it intended to strip away the government‘s power to consent to settlements made in its name. The right of the United States to veto a settlement purportedly made on its behalf is entirely consistent with an intention to foster qui tam litigation. By providing financial incentives and limiting the opportunity for the government to completely take over a qui tam action after the initial sixty-day period, the 1986 amendments certainly “encouraged more private enforcement” of the Act. Indeed, nowhere in the legislative history relied upon by the Killingsworth court, or anywhere else in the 1986 amendments, does Congress evince an intention to limit the
Finally, Appellees assert that because
To the extent any separation of powers issues exist, they are not abated by limiting the consent provision to the sixty day period. If the consent provision impermissibly infringes upon Article III jurisdiction, the constitutional harm is not cured
Appellees’ mootness contention is also misplaced. Their mootness argument fails to appreciate that a relator acts on the government‘s behalf, acts to vindicate governmental interests, and that the government is the real party in interest. See supra. As noted before, the relator would not have standing to bring an FCA claim if it were not clear that she acted in the government‘s stead. Thus, if the government‘s interests are adverse to those reflected in a putative settlement agreement, a live controversy undoubtedly exists.
III.
In sum, we find nothing in the structure of
For more than 130 years, Congress has instructed courts to let the government stand on the sidelines and veto a voluntary settlement. It would take a serious conflict within the structure of the False Claims Act or a profound gap in the reasonableness of the provision for us to be able to justify ignoring this language. We can find neither.
Searcy, 117 F.3d at 160. We agree with this conclusion, and hold that a qui tam plaintiff may not seek a voluntary dismissal of any action under the False Claims Act without the Attorney General‘s consent. Accordingly, we VACATE the judgment of the district court, and REMAND this case for further proceedings.
